Ipca Laboratories Limited (BOM:524494)
1,445.50
+17.10 (1.20%)
At close: Dec 3, 2025
Ipca Laboratories Revenue
Ipca Laboratories had revenue of 25.57B INR in the quarter ending September 30, 2025, with 8.56% growth. This brings the company's revenue in the last twelve months to 93.59B, up 9.66% year-over-year. In the fiscal year ending March 31, 2025, Ipca Laboratories had annual revenue of 89.41B with 16.03% growth.
Revenue (ttm)
93.59B
Revenue Growth
+9.66%
P/S Ratio
3.96
Revenue / Employee
5.58M
Employees
16,778
Market Cap
370.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 89.41B | 12.35B | 16.03% |
| Mar 31, 2024 | 77.06B | 14.58B | 23.33% |
| Mar 31, 2023 | 62.48B | 4.18B | 7.16% |
| Mar 31, 2022 | 58.31B | 4.10B | 7.56% |
| Mar 31, 2021 | 54.21B | 7.71B | 16.58% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |
Ipca Laboratories News
- 17 days ago - Ipca Laboratories Ltd (BOM:524494) Q2 2026 Earnings Call Highlights: Strong Domestic Growth ... - GuruFocus
- 17 days ago - Q2 2026 IPCA Laboratories Ltd Earnings Call Transcript - GuruFocus
- 23 days ago - Ipca Laboratories Q2 FY26 results: Revenue up 9% YoY to Rs 2,556.5 crore, Net profit rises 23% - Business Upturn
- 2 months ago - Ipca and BioSimilar Sciences sign Technology Transfer Agreement for next-gen cancer and anti-inflammatory biosimilar - Business Upturn
- 4 months ago - Ipca Laboratories Q1 results: Net profit surges 21% YoY to Rs 233.21 crore, revenue up 10.3% - Business Upturn
- 4 months ago - Top Q1 results today, August 11: SJVN, BEML, Bata India, Titagarh Rail, Ipca Laboratories and more to announce earnings - Business Upturn
- 6 months ago - IPCA Laboratories shares dip over 2% after HSBC cuts target price to Rs 1,330 - Business Upturn
- 6 months ago - IPCA Laboratories Q4 results: Revenue jumps 10.50% YoY to Rs 2,247 crore, net profit up 14.1% YoY - Business Upturn